★ Sign in to follow
US

Ugur Sahin

CEO
US·SEC (Form 4)
BioNTech SE
Insider activity · 24 months0 buys26 salesCumulative net flow
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (26 ops.)
€73.6M

Latest filing published 09 Oct 2026 for BioNTech SE, €2.2M.

Filing timeline

BuySale
Ugur Sahin

Insider track record

Disclosed buys
0
Disclosed sells
26
Signal history

Ugur Sahin: trading record in brief

All filings by Ugur Sahin on record concern BioNTech SE. We count 26 filings; the first trade dates from 3 September 2026 and the latest from 9 October 2026.

Every open-market trade on record is a sale: 26 sales worth €73.6M.

Most recently, on 9 October 2026, the filings show an open-market sale worth €2.2M in BioNTech SE. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ugur Sahin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations26 total
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD0SEC
    27,000 shares@ US$92.3142Ordinary SharesSEC:0002123975-26-000035:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD0SEC
    36,209 shares@ US$95.3733Ordinary SharesSEC:0002123975-26-000035:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD26SEC
    24,000 shares@ US$95.85970.0094% mcap3.0% of flowOrdinary SharesSEC:0002123975-26-000033:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    7M USD30SEC
    72,000 shares@ US$97.23120.029% mcap9.4% of flowOrdinary SharesSEC:0002123975-26-000031:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD26SEC
    21,000 shares@ US$96.80930.0083% mcap2.7% of flowOrdinary SharesSEC:0002123975-26-000031:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD25SEC
    17,000 shares@ US$97.45560.0067% mcap2.5% of flowOrdinary SharesSEC:0002123975-26-000029:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD25SEC
    17,000 shares@ US$96.72490.0067% mcap2.5% of flowOrdinary SharesSEC:0002123975-26-000029:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD28SEC
    34,000 shares@ US$98.25910.014% mcap5.3% of flowOrdinary SharesSEC:0002123975-26-000027:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD28SEC
    32,000 shares@ US$98.12030.013% mcap5.0% of flowOrdinary SharesSEC:0002123975-26-000027:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD25SEC
    27,000 shares@ US$98.68820.012% mcap4.7% of flowOrdinary SharesSEC:0002123975-26-000025:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    34,000 shares@ US$98.46820.015% mcap5.9% of flowOrdinary SharesSEC:0002123975-26-000025:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    30,000 shares@ US$99.40270.013% mcap5.9% of flowOrdinary SharesSEC:0002123975-26-000023:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    4M USD26SEC
    39,000 shares@ US$98.99130.017% mcap7.7% of flowOrdinary SharesSEC:0002123975-26-000023:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    33,000 shares@ US$97.80970.014% mcap6.3% of flowOrdinary SharesSEC:0002123975-26-000021:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    5M USD27SEC
    46,000 shares@ US$100.71820.021% mcap9.1% of flowOrdinary SharesSEC:0002123975-26-000021:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    34,000 shares@ US$98.59830.015% mcap6.6% of flowOrdinary SharesSEC:0002123975-26-000019:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    30,000 shares@ US$96.22430.013% mcap5.7% of flowOrdinary SharesSEC:0002123975-26-000019:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    3M USD26SEC
    34,000 shares@ US$96.48930.014% mcap6.4% of flowOrdinary SharesSEC:0002123975-26-000017:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    1M USD23SEC
    15,000 shares@ US$96.08930.0063% mcap2.8% of flowOrdinary SharesSEC:0002123975-26-000017:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    4M USD27SEC
    45,000 shares@ US$96.93380.019% mcap8.5% of flowOrdinary SharesSEC:0002123975-26-000015:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    4M USD27SEC
    41,000 shares@ US$99.44670.018% mcap7.9% of flowOrdinary SharesSEC:0002123975-26-000015:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    2M USD24SEC
    20,500 shares@ US$96.30670.0086% mcap3.8% of flowOrdinary SharesSEC:0002123975-26-000013:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    4M USD26SEC
    37,000 shares@ US$99.20320.016% mcap7.1% of flowOrdinary SharesSEC:0002123975-26-000011:0
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    4M USD26SEC
    36,000 shares@ US$97.78180.015% mcap6.8% of flowOrdinary SharesSEC:0002123975-26-000011:1
  • ▼
    Ugur Sahin
    Chief Executive OfficerExecutivesBioNTech SE
    5M USD27SEC
    45,000 shares@ US$102.84960.020% mcap9.0% of flowOrdinary SharesSEC:0002123975-26-000008:0

25 of 26 declarations

Related entities

No related entities found.